Holly Peay

Join Holly Peay, a Senior Research Scientist at RTI and leader of the Early Check Study, as she breaks down the complexities of newborn genome screening. She discusses ethical challenges, the balance of choice in genetic decision-making, and the significance of using polygenic risk scores. Holly shares insights on the Early Check program's impact, including enrollment statistics and the rationale behind including type 1 diabetes risk scores. Tune in for a fascinating dive into how cutting-edge genetics can reshape early healthcare.